NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-219-2018-2-JP-06 A Fully Automated System For Quantitative Myocardial Perfusion Pixel Mapping And Machine Diagnosis To Detect Ischemic Heart Disease With First-pass Perfusion Cardiac Magnetic Resonance Imaging JP National Stage 2021-514658 Issued
NHLBI E-219-2018-2-CA-02 A Fully Automated System For Quantitative Myocardial Perfusion Pixel Mapping And Machine Diagnosis To Detect Ischemic Heart Disease With First-pass Perfusion Cardiac Magnetic Resonance Imaging CA National Stage 3085303 Abandoned
NHLBI E-219-2018-2-KR-05 A Fully Automated System For Quantitative Myocardial Perfusion Pixel Mapping And Machine Diagnosis To Detect Ischemic Heart Disease With First-pass Perfusion Cardiac Magnetic Resonance Imaging KR National Stage 10-2020-7036354 Issued
NCATS E-098-2019-0-US-01 A SCALABLE SYNTHESIS OF DUAL-TARGET INHIBITOR OF CANNABINOID-1 RECEPTOR AND INDUCIBLE NITRIC OXIDE SYNTHASE US 62/849,193 Abandoned
NCATS E-035-2020-0-US-01 TREATING PRIMARY OR IDIOPATHIC HYPEROXALURIA WITH SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE US 62/849,564 Abandoned
NIAID E-086-2018-3-US-02 Zika Viral Antigen Constructs US National Stage 16/461,503 11780885 Issued PDF
NIA E-279-2013-0-US-04 METHODS FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS US DIV 16/414,025 10808222 Issued PDF
NCI E-150-2018-0-PCT-02 CATALYTICALLY HYPERACTIVE VARIANTS OF HUMAN APOBEC3G PROTEIN PCT PCT PCT/US2019/032720 Expired
NCATS E-114-2018-0-PCT-02 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS PCT PCT PCT/US2019/32461 Expired
NCATS E-114-2018-0-CA-04 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS CA National Stage 3100211 Pending
NCI E-040-2012-0-TM-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen TM EA 201990959 Issued
NCI E-040-2012-0-TJ-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen TJ EA 201990959 Issued
NCI E-040-2012-0-EA-31 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen EA DIV 201990959 Issued
NCI E-040-2012-0-RU-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen RU EA 201990959 Issued
NCI E-040-2012-0-KG-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KG EA 201990959 Issued
NCI E-040-2012-0-KZ-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KZ EA 201990959 Issued
NCI E-040-2012-0-BY-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen BY EA 201990959 Issued
NCI E-040-2012-0-AZ-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AZ EA 201990959 Issued
NCI E-040-2012-0-AM-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AM EA 201990959 Issued
NCI E-121-2013-0-US-05 METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF CANCER US CON 16/412,003 11555818 Issued PDF
NLM E-107-2010-2-US-26 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/411,998 10793899 Issued PDF
CC E-136-2016-1-US-03 Imageable Polymers, Methods of Making and Methods of Use Thereof US National Stage 16/349,458 11382990 Issued PDF
NCI E-174-2012-0-US-03 METHODS OF PRODUCING T MEMORY STEM CELL POPULATIONS US DIV 16/410,327 11111478 Issued PDF
NCI E-070-2015-0-US-06 Optimal Dosing Of Heterodimeric Interleukin-15 (IL-15) US CON 16/411,062 Abandoned
NCATS E-095-2018-0-PCT-02 QUINOLINE COMPOUNDS AND THEIR PREPARATION AND USE AS ANTIMALARIAL AGENTS PCT PCT PCT/US2019/031987 Expired
NCI E-508-2013-2-CN-12 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE CN DIV 201910393592.0 Issued
NCI E-495-2013-0-US-11 ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS US CON 16/408,939 10913785 Issued PDF
NIMH E-259-2016-0-US-04 Radiolabeling Agents, Methods of Making, and Methods of Use Thereof US National Stage 16/349,124 Abandoned
NEI E-293-2016-0-US-03 TISSUE CLAMP AND IMPLANTATION METHOD US National Stage 16/348,855 11717298 Issued PDF
NIAID E-053-2018-1-US-02 Methods Of Treating And Inhibiting Ebola Virus Infection US National Stage 16/348,867 11617753 Issued PDF
NCI E-075-2018-0-PCT-01 HEXAMERIC TETRAHEDRAL RNA NANOSTRUCTURES PCT PCT COMB PCT/US2019/031356 Expired
NHLBI E-085-2019-1-US-01 METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE US 62/844,957 Abandoned
NEI E-004-2017-0-US-03 3D VASCULARIZED HUMAN OCULAR TISSUE FOR CELL THERAPY AND DRUG DISCOVERY US National Stage 16/347,939 11458225 Issued PDF
NCI E-064-2019-0-US-01 CHIMERIC ANTIGEN RECEPTORS TARGETING GLYCIPAN-2 US 62/844,695 Abandoned
NCI E-169-2016-0-AU-03 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS AU National Stage 2017355564 Issued
NCI E-022-2017-0-US-04 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT US National Stage 16/347,778 11312998 Issued PDF
NCI E-169-2016-0-US-06 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS US National Stage 16/347,764 11311613 Issued PDF
NCI E-022-2017-0-EP-03 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT EP National Stage 17805342.7 Issued
NCI E-022-2017-0-GB-08 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT GB EP 17805342.7 Issued
NCI E-022-2017-0-DE-07 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT DE EP 17805342.7 Issued
NCI E-022-2017-0-FR-06 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT FR EP 17805342.7 Issued
NIAID E-357-2001-1-AU-31 WEST NILE VIRUS AND DENGUE 4 VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS AU DIV 2019203166 Expired
NCI E-123-2018-0-EP-03 PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF EP National Stage 19724994.9 Issued
NEI E-293-2016-0-AU-04 TISSUE CLAMP AND IMPLANTATION METHOD AU National Stage 2017359336 Issued
NIAID E-239-2014-0-US-07 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE US DIV 16/403,211 10759846 Issued PDF
NCI E-123-2018-0-PCT-02 PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF PCT PCT PCT/US2019/030656 Expired
NIAID E-087-2019-0-US-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US 62/842,590 Abandoned
NIAID E-079-2018-0-PCT-01 ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION PCT PCT COMB PCT/US2019/030431 Expired
NIAID E-079-2018-0-EP-02 ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION EP National Stage 19724039.3 Pending
NCI E-098-2018-0-PCT-02 T CELL RECEPTORS WHICH RECOGNIZE MUTATED EGFR PCT PCT PCT/US2019/030108 Expired